Quality, tone, and misinformation in TikTok content about RSV immunization for pregnant people and infants (2023 to 2025): a cross-sectional content analysis
Respiratory syncytial virus (RSV) is a major cause of infant hospitalization. Since 2023, families have had two prevention options: a maternal vaccine given in pregnancy or an antibody shot, nirsevimab, given to infants. Many parents use social media to help decide. We reviewed 169 public TikTok videos about RSV immunization posted between July 2023 and November 2025, rating quality on a 1 to 5 scale and coding creator type, misinformation status, tone, and narrative framing. Median quality was 3, and 47% of videos were high quality. Health professionals made half of all videos and most evidence-consistent content, while parents and caregivers made a larger share of mixed-or-uncertain content. Mixed-or-uncertain videos (20%) were more than six times as common as outright misinformation (3%). Most videos (73%) used a protective, child-focused frame, regardless of accuracy. Clinicians should ask families what they have seen online and be ready to offer reliable resources.
Authors
- Shivani Srivastava (ORCID: https://orcid.org/0009-0006-3597-5301)
- Grace Smithwick
- Angelica Pavesio
- Kathryn Whitehill
- Shruti Shah
Institutions
- Rutgers, The State University of New Jersey (US)
- Rutgers New Jersey Medical School (US)
Publication Details
- Journal
- Vaccine
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1016/j.vaccine.2026.129373
- Primary Topic
- Social Media in Health Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00